Table 1 Baseline subject characteristics

From: Chronic nicotinamide riboside supplementation is well-tolerated and elevates NAD+ in healthy middle-aged and older adults

Subject characteristic Group A Group B All subjects combined
Sex (M/F) 5/7 6/6 11/13
Age (years) 64 ± 6 66 ± 9 65 ± 7
Mass (kg) 67 ± 16 69 ± 14 68 ± 15
BMI (kg m−2) 23 ± 4 24 ± 3 24 ± 4
Total body fat (%) 27 ± 10 29 ± 11 28 ± 10
Systolic blood pressure (mmHg) 122 ± 18 120 ± 17 121 ± 17
Diastolic blood pressure (mmHg) 77 ± 11 72 ± 9 74 ± 10
Fasting glucose (mg dl−1) 89 ± 8 87 ± 8 88 ± 8
Total cholesterol (mg dl−1) 192 ± 38 183 ± 36 187 ± 36
HDL cholesterol (mg dl−1) 69 ± 12 69 ± 25 69 ± 19
LDL cholesterol (mg dl−1) 107 ± 36 94 ± 23 101 ± 30
  1. Includes all subjects who completed the study (N = 24) by randomization group (A = placebo, NR; B = NR, placebo) and in all subjects combined. Data are mean ± SD.
  2. BMI body mass index, HDL high-density lipoprotein, LDL low-density lipoprotein